Binding of gluten-derived peptides to the HLA-DQ2 (α1*0501, β1*0201) molecule, assessed in a cellular assay
- 1 January 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 111 (1) , 158-165
- https://doi.org/10.1046/j.1365-2249.1998.00448.x
Abstract
The nature of the immunopathogenic relationship underlying the very strong association of coeliac disease (CD) to the HLA-DQ (A1*0501, B1*0201) genotype is not known, but probably relates to binding of gluten-derived epitopes to the HLA-DQ (α1*0501, β1*0201) heterodimer (DQ2). These epitopes have not yet been defined. In this study we have tested the binding of various gluten-derived peptides to DQ2 in a cellular assay using Epstein–Barr virus (EBV)-transformed B lymphocytes and murine fibroblast transfectants. One of these peptides (peptide A), which has previously been shown to exacerbate the CD lesion in vitro and in vivo, was found to bind to DQ2, albeit only moderately, lending further credence to its possible role in the pathogenesis of CD. The nature of peptide A's binding to DQ2 was explored with truncated and conservative point substituted analogues and compared with the published DQ2 binding motif, the results of which explain the observed level of binding.Keywords
This publication has 35 references indexed in Scilit:
- Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modellingInternational Immunology, 1996
- Binding of Peptides from the N-Terminal Region of α-Gliadin to the Celiac Disease-Associated HLA-DQ2 Molecule Assessed in Biochemical and T Cell AssaysClinical Immunology and Immunopathology, 1996
- T Cells from the Peripheral Blood of Coeliac Disease Patients Recognize Gluten Antigens when Presented by HLA‐DR, ‐DQ, or ‐DP MoleculesScandinavian Journal of Immunology, 1994
- T cells recognize a peptide derived from α-gliadin presented by the celiac disease-associated HLA-DQ (α1∗0501, β1∗0201) heterodimerHuman Immunology, 1994
- Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptideNature, 1994
- Celiac disease among Ashkenazi Jews from IsraelHuman Immunology, 1993
- Efficient cDNA expression vectors for stable and transient expression of HLA-DR in transfected fibroblast and lymphoid cellsHuman Immunology, 1991
- Regulation of antigen presentation by acidic pH.The Journal of Experimental Medicine, 1990
- Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell SrfacesInternational Immunology, 1990
- Sequence analysis of HLA class II genes from insulin-dependent diabetic individualsHuman Immunology, 1988